The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis

Figure 5

Forest plot comparing serum VEGF levels in MM patients treated with the T-VAD regimen or the VAD regimen.